253 related articles for article (PubMed ID: 31793501)
41. Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates.
Peretokina IV; Krylova LY; Antonova OV; Kholina MS; Kulagina EV; Nosova EY; Safonova SG; Borisov SE; Zimenkov DV
J Infect; 2020 May; 80(5):527-535. PubMed ID: 31981638
[TBL] [Abstract][Full Text] [Related]
42. The importance of heteroresistance and efflux pumps in bedaquiline-resistant Mycobacterium tuberculosis isolates from Iran.
Madadi-Goli N; Ahmadi K; Kamakoli MK; Azizi M; Khanipour S; Dizaji SP; Nasehi M; Siadat SD; Fateh A; Vaziri F
Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):36. PubMed ID: 38664815
[TBL] [Abstract][Full Text] [Related]
43. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S
PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759
[TBL] [Abstract][Full Text] [Related]
44. In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis.
Lounis N; Vranckx L; Gevers T; Kaniga K; Andries K
Med Mal Infect; 2016 Jun; 46(4):220-5. PubMed ID: 27210281
[TBL] [Abstract][Full Text] [Related]
45. Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains.
Battaglia S; Spitaleri A; Cabibbe AM; Meehan CJ; Utpatel C; Ismail N; Tahseen S; Skrahina A; Alikhanova N; Mostofa Kamal SM; Barbova A; Niemann S; Groenheit R; Dean AS; Zignol M; Rigouts L; Cirillo DM
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32907992
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of BACTEC MGIT 960 system for the second-line drugs susceptibility testing of Mycobacterium tuberculosis in China.
Zhao LL; Xia Q; Lin N; Liu B; Zhao XQ; Liu Z; Wan KL
J Microbiol Methods; 2012 Oct; 91(1):212-4. PubMed ID: 22766324
[TBL] [Abstract][Full Text] [Related]
47. [Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].
Tuberculosis Research Committee
Kekkaku; 2007 Mar; 82(3):155-64. PubMed ID: 17444118
[TBL] [Abstract][Full Text] [Related]
48. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
[TBL] [Abstract][Full Text] [Related]
49. Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.
Xu J; Wang B; Hu M; Huo F; Guo S; Jing W; Nuermberger E; Lu Y
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320727
[TBL] [Abstract][Full Text] [Related]
50. Performance of BACTEC 960 Mycobacteria growth indicator tube in the susceptibility testing of genetically characterized Mycobacterium tuberculosis isolates.
Marttila HJ; Marjamäki M; Viljanen MK; Soini H
Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):757-9. PubMed ID: 14605940
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion.
Tortoli E; Benedetti M; Fontanelli A; Simonetti MT
J Clin Microbiol; 2002 Feb; 40(2):607-10. PubMed ID: 11825978
[TBL] [Abstract][Full Text] [Related]
52. Revisiting problems and solutions to decrease Mycobacterium tuberculosis pyrazinamide false resistance when using the Bactec MGIT 960 system.
Mustazzolu A; Piersimoni C; Iacobino A; Giannoni F; Chirullo B; Fattorini L
Ann Ist Super Sanita; 2019; 55(1):51-54. PubMed ID: 30968836
[TBL] [Abstract][Full Text] [Related]
53. Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.
Liu Y; Gao J; Du J; Shu W; Wang L; Wang Y; Xue Z; Li L; Xu S; Pang Y
Int J Infect Dis; 2021 Jan; 102():392-396. PubMed ID: 33130209
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the BACTEC MGIT 960 SL DST Kit and the GenoType MTBDRsl Test for Detecting Extensively Drug-resistant Tuberculosis Cases.
Tekin K; Albay A; Simsek H; Sig AK; Guney M
Eurasian J Med; 2017 Oct; 49(3):183-187. PubMed ID: 29123441
[TBL] [Abstract][Full Text] [Related]
55. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB.
Ejigu GS; Woldeamanuel Y; Shah NS; Gebyehu M; Selassie A; Lemma E
Int J Tuberc Lung Dis; 2008 Mar; 12(3):332-7. PubMed ID: 18284841
[TBL] [Abstract][Full Text] [Related]
56. Improving antitubercular drug susceptibility testing with liquid media.
Hwang SM; Hwang KC; Hong YJ; Lee HR; Kim TS; Park KU; Song J; Lee JH; Kim EC
Ann Clin Lab Sci; 2014; 44(2):123-30. PubMed ID: 24795049
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
[TBL] [Abstract][Full Text] [Related]
58. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
Kobayashi I; Abe C; Mitarai S
Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006
[TBL] [Abstract][Full Text] [Related]
59. Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system.
Koh WJ; Ko Y; Kim CK; Park KS; Lee NY
Ann Lab Med; 2012 Jul; 32(4):264-9. PubMed ID: 22779067
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the nitrate-based colorimetric method for testing the susceptibility of Mycobacterium tuberculosis to streptomycin and ethambutol in liquid cultures.
Syre H; Valvatne H; Sandven P; Grewal HM
J Antimicrob Chemother; 2006 May; 57(5):987-91. PubMed ID: 16524896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
